Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01648673 · ClinicalTrials.gov registry record
Pilot Evaluation of the JHI Platform
A clinical trial, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 500
- Enrollment target
NCT01648673: Completed study, sponsored by Henry Ford Health System.
NCT01648673 is a clinical trial that has completed, run by Henry Ford Health System. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01648673 has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
The main purpose of this pilot study is to evaluate an impact of JHI CR Platform on patient referral, recruitment and retention rates and overall patient satisfaction in cardiovascular rehabilitation programs at the HFHS.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2012-08 |
| Est. Completion | 2017-04 |
What the finished NCT01648673 record still lists
NCT01648673 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01648673 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01648673 about?
NCT01648673 is a clinical study titled "Pilot Evaluation of the JHI Platform". The main purpose of this pilot study is to evaluate an impact of JHI CR Platform on patient referral, recruitment and retention rates and overall patient satisfaction in cardiovascular rehabilitation programs at the HFHS.
What is the current status of trial NCT01648673?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2012-08. Estimated completion is 2017-04.
Who is sponsoring clinical trial NCT01648673?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia